| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ZFPM2 antisense RNA 1 | 0.736 | 0.385 |
|
phenotype | 0.100 | None | 1.000 | 5 | 2 | 2011 | 2019 | |||||||||
|
STARD4 antisense RNA 1 | 0.890 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2018 | |||||||||
|
long intergenic non-protein coding RNA 1478 | 1.000 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2018 | |||||||||
|
MEF2C antisense RNA 1 | 0.861 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | |||||||||
|
long intergenic non-protein coding RNA 1221 | 1.000 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2018 | |||||||||
|
MIR181A1 host gene | 0.861 | 0.115 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
smooth muscle and endothelial cell enriched migration/differentiation-associated lncRNA | 0.931 | 0.038 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
long intergenic non-protein coding RNA 1476 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||||
|
small nucleolar RNA host gene 30 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||||
|
BCL2L1 antisense RNA 1 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||||
|
long intergenic non-protein coding RNA 2068 | 0.931 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
RNA, U6 small nuclear 950, pseudogene |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||||
|
HLA complex P5 | 0.595 | 0.808 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
ACTN1 antisense RNA 1 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||||
|
coiled-coil domain containing 162, pseudogene | 0.890 | 0.154 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase | 0.427 | 0.885 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
HNF1A antisense RNA 1 | 0.621 | 0.538 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
long intergenic non-protein coding RNA 1091 | 0.821 | 0.231 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
cancer susceptibility 15 | 0.603 | 0.577 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||
|
MIR4435-2 host gene | 0.604 | 0.692 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
MIR3936 host gene | 0.861 | 0.269 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
long intergenic non-protein coding RNA 461 | 0.736 | 0.423 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
glutathione S-transferase alpha 11, pseudogene |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||||
|
PDYN antisense RNA 1 | 1.000 | 0.077 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | |||||||||
|
CD36 molecule | 0.446 | 0.846 | 1.1E-60 |
|
phenotype | 0.100 | None | 1.000 | 4 | 4 | 2012 | 2019 |